Homeopathic treatment of white patch

Efficacy of Individualized Homoeopathic Medicines in Treatment of Vitiligo: Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/016160

Enrollment

Registered

2018-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Individualised homoeopathic medicines in 50 millesimal potencies: Intervention is planned as administering indicated homoeopathic medicines in fifty-millesimal potencies, as decided app

16 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

dosage and repetition depending upon the individual requirement of the cases. All medicines will be procured from a Good Manufacturing Practice (GMP)-certified firm. Duration of therapy: 6 months. Con

dosage and repetition depending upon the individual requirement of the cases. Duration of therapy: 6 months.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Suffering from Vitiligo for at least last 3 months 2. Patients of both sexes 3. Age between 18-65 years 4. Literate; able to read English and/or Bengali 5. Patients who have not taken any treatment since last 2 weeks for Vitiligo

Exclusion criteria

Exclusion criteria: 1. Patients who are too sick for consultation 2. Unwilling to take part and not giving consent to join the study 3. Unable to read patient information sheet 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life- threatening illness affecting quality of life or any organ failure 5. Pregnancy and lactation 6. Substance abuse and/or dependence 7. Self-reported immune-compromised state 8. Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Design outcomes

Primary

Measure	Time frame
Vitiligo area scoring index (VASI) evaluateing disease extent and severityTimepoint: At baseline, 3rd month and 6th month	—

Secondary

Measure	Time frame
Dermatological Life Quality Index (DLQI) questionnaireTimepoint: At baseline, 3rd month and 6th month;Vitiligo Specific Health Related Quality of Life Instrument (VitiQOL)Timepoint: At baseline, 3rd month and 6th month	—

Countries

India

Contacts

Public ContactSwapan Paul

National Institute of Homoeopathy

drspaul.2007@gmail.com9830148968

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 13, 2026